BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21565670)

  • 1. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):682-6. PubMed ID: 15761539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
    Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
    J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-remediable aldosteronism.
    Dluhy RG; Lifton RP
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):285-97. PubMed ID: 8070423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucocorticoid remediable aldosteronism].
    Omura M; Nishikawa T
    Nihon Rinsho; 2006 May; Suppl 1():628-34. PubMed ID: 16776234
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucocorticoid remediable aldosteronism: a case report.
    Hsieh CJ; Wang PW; Liu JC; Tung SC; Chien WY; Lu YC; Kuo MC
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):52-7. PubMed ID: 9178594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.
    Lifton RP; Dluhy RG; Powers M; Rich GM; Cook S; Ulick S; Lalouel JM
    Nature; 1992 Jan; 355(6357):262-5. PubMed ID: 1731223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
    Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
    J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A German family with glucocorticoid-remediable aldosteronism.
    Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
    Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
    Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis of glucocorticoid-remediable aldosteronism, a Mendelian cause of human hypertension.
    Lifton RP; Dluhy RG; Powers M; Ulick S; Lalouel JM
    Trans Assoc Am Physicians; 1992; 105():64-71. PubMed ID: 1309006
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial hyperaldosteronism.
    Torpy DJ; Stratakis CA; Chrousos GP
    Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
    Ding W; Liu L; Hu R; Xu M; Chen J
    Chin Med J (Engl); 2002 Jul; 115(7):979-82. PubMed ID: 12150724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism.
    Litchfield WR; New MI; Coolidge C; Lifton RP; Dluhy RG
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3570-3. PubMed ID: 9360508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
    Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperaldosteronism in pregnancy.
    Escher G
    Ther Adv Cardiovasc Dis; 2009 Apr; 3(2):123-32. PubMed ID: 19171690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal salt-wasting and 11 beta-hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosterone synthase)-CYP11B1 (11 beta-hydroxylase).
    Ezquieta B; Luzuriaga C
    Clin Genet; 2004 Sep; 66(3):229-35. PubMed ID: 15324322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
    Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.